Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Wary of Mad Cow Disease, US Restricts Blood Donors

By HospiMedica staff writers
Posted on 17 Sep 2001
To reduce the risk of transmission of variant Creutzfeldt-Jakob disease (vCJD) to recipients of blood and blood products, the U.S. More...
Food and Drug Administration (FDA) has issued more restrictive guidelines on donors. Based on the best available science, the guidelines are designed to exclude donors who may have been exposed to the agent of bovine spongiform encephalopathy (BSE, or mad cow disease), which has been linked to vCJD.

According to the new guidelines, by May 31, 2002, donors should be deferred who have spent three or more cumulative months in the United Kingdom from the beginning of 1980 through the end of 1996, as should donors who have spent five cumulative years or more in France from 1980 to the present. By October 31, 2002, donors should be deferred who have spent five cumulative years or more in Europe from 1980 until the present.

Currently, vCJD is not known to have been transmitted by blood transfusion, nor have any cases of the disease been reported in the United States. However, the FDA notes that animal models suggest that transmission by blood products may be possible. Also, cases of vCJD in the U.K. continue to increase, while BSE has become widespread in Europe.




Related Links:
FDA

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Resorbable Bovine Collagen Membrane
GenDerm
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.